HEALTH● LOWAug 27 · Aug 27, 2026, 9:49 PM
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
CNBC · north america
The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoHit a midlife wall? This test identifies your strengths and what matters to youNPR NewsHEALTH1h agoKerala State Drugs Control dept. seeks curbs on inter-State drug procurement to ensure traceabilityThe HinduHEALTH1h ago93% of children affected by diphtheria outbreaks not fully vaccinated – OfficialPremium TimesHEALTH1h agoDr. Sandra G. Martín, dentist: "Health always comes before a pretty tooth. First biology and then aesthetics. The important thing is that everything is healthy."Clarín